Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
45,101,565
-
Total 13F shares
-
26,332,523
-
Share change
-
+4,095,922
-
Total reported value
-
$796,209,961
-
Price per share
-
$30.24
-
Number of holders
-
116
-
Value change
-
+$116,007,549
-
Number of buys
-
72
-
Number of sells
-
44
Institutional Holders of Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) as of Q1 2021
As of 31 Mar 2021,
Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) was held by
116 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,332,523 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Sofinnova Investments, Inc., STATE STREET CORP, VANGUARD GROUP INC, FMR LLC, Artisan Partners Limited Partnership, ALLIANCEBERNSTEIN L.P., Cormorant Asset Management, LP, and First Light Asset Management, LLC.
This page lists
116
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.